Advanced Search

 

Study ID Status Title Patient Level Data
29060/475 Completed Pharmacokinetic study of paroxetine hydrochloridePharmacokinetics after single oral administration of paroxetine hydrochloride 20 mg to healthy elderly volunteers
29060/480 Completed A single-dose, two-period crossover study to demonstrate bioequivalence between the controlled-release paroxetine tablet (50 mg) manufactured at Cidra and two 25 mg controlled-release tablets manufactured at Crawley
29060/485 Completed An open 3 part crossover study to examine the bioavailability characteristics of slow release oral formulations of paroxetine (30 mg dose), in comparison with a standard, immediate release 30 mg tablet, in healthy volunteers
29060/486 Completed The effects of paroxetine on the pharmacodynamics and pharmacokinetics of terfenadine in healthy adult males
29060/487 Completed A Double-Blind, Placebo Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Controlled Release Paroxetine in the Treatment of Major Depression in Elderly Patients Study Listed on ClinicalStudyDataRequest.com
29060/494 Completed A Double-Blind, Placebo-Controlled, Flexible-Dosing Trial to Evaluate the Efficacy of Modified-Release Paroxetine in the Treatment of Panic Disorder Study Listed on ClinicalStudyDataRequest.com
29060/495 Completed A Double-Blind, Placebo-Controlled, Flexible-Dosing Trial to Evaluate the Efficacy of Controlled-Release Paroxetine in the Treatment of Panic Disorder Study Listed on ClinicalStudyDataRequest.com
29060/497 Completed A Double-Blind, Placebo-Controlled, Flexible-Dosing Trial to Evaluate the Efficacy of Controlled-Release Paroxetine in the Treatment of Panic Disorder Study Listed on ClinicalStudyDataRequest.com
29060/502 Completed A Randomised, Double-blind Study of Paroxetine and Placebo in the Treatment of Social Phobia Study Listed on ClinicalStudyDataRequest.com
29060/505 Completed An open 4 part crossover study to examine the bioavailability characteristics of the paroxetine enteric-coated geomatrix tablet (25 mg) and two novel formulations of the paroxetine geomatrix tablet (20 mg), in comparison with a standard immediate-release paroxetine (20 mg) tablet in healthy volu ...
29060/509 Completed An open, non-comparative multi-centre study to assess the efficacy and tolerability of paroxetine 20mg daily in the treatment of depression and depression associated with anxiety
29060/512 Completed A multi-centre, double-blind placebo-controlled study to investigate the effect of pindolol on the onset of antidepressant activity of paroxetine in the treatment of depression.
29060/516 Completed A post-marketing surveillance to monitor the safety of Seroxat (paroxetine hydrochloride) administered in Korean subjects according to the prescribing information.
29060/517 Completed An open 3 way crossover study to examine the effect of paroxetine on the pharmacokinetics of pindolol, in healthy volunteers.
29060/518 Completed A multi-centre, double-blind, double dummy, randomised controlled study to investigate the speed of onset, safety, efficacy and tolerability of paroxetine in combination with pindolol compared with dothiepin in the treatment of depression.
29060/523 Completed Open prospective study to evaluate the efficacy and safety of paroxetine in the treatment of Panic Disorder and Obsessive-Compulsive Disorder
29060/524 Completed An open multicentre prospective study to compare antidepressive activity of paroxetine in monotherapy and paroxetine combined with pindolol in the treatment of depression
29060/525 Completed A double blind, multicenter randomized drug-controlled study to assess the efficacy and tolerance of paroxetine compared with clomipramine in treatment of panic disorder.
29060/526 Completed A double blind, multicenter, randomized, drug-controlled study to assess the efficacy and tolerance of paroxetine compared with clomipramine in treatment of obsessive compulsive disorder.
29060/533 Completed A study to demonstrate the bioequivalence between the paroxetine capsule and the Paxil tablet formulations at the highest and lowest dosage strengths.
29060/536 Completed A Randomized, Open Trial to Compare Patient Medication Compliance, Efficacy and Quality of Life in Patients Receiving Paroxetine, (20 mg OD) Dispensed in Bottles Compared with Paroxetine, (20 mg OD) Dispensed in Blister Packaging
29060/539 Completed A single dose two-period crossover study to demonstrate bioequivalence between the controlled release paroxetine tablet (25 mg) manufactured at Cidra and Crawley
29060/560 Completed A single dose two-period cross-over study to compare the bioavailability of a paroxetine/pindolol combination tablet (containing 20 mg paroxetine and 7.5 mg controlled release pindolol) when administered in the fed and fasted state
29060/563 Completed A single dose, five-period crossover study to assess the bioavailability of paroxetine from the controlled release paroxetine tablet (50 mg) when administered in four different fed states relative to administration in the fasted state.
29060/564 Completed A steady state study to assess the pharmacokinetic profile of paroxetine after repeated daily dosing of the controlled release paroxetine tablet (25 mg) when given fasted and when given immediately after a standard FDA high-fat breakfast

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.